Handelsbanken Fonder’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-33,800
Closed -$433K 1533
2026
Q1
$433K Hold
33,800
﹤0.01% 1336
2025
Q4
$304K Buy
+33,800
New +$465K ﹤0.01% 1432
2025
Q2
Sell
-34,700
Closed -$247K 1552
2025
Q1
$247K Hold
34,700
﹤0.01% 1457
2024
Q4
$405K Buy
34,700
+2,300
+7% +$35.9K ﹤0.01% 1373
2024
Q3
$666K Buy
32,400
+6,300
+24% +$145K ﹤0.01% 1118
2024
Q2
$584K Buy
26,100
+7,100
+37% +$169K ﹤0.01% 1084
2024
Q1
$523K Hold
19,000
﹤0.01% 1145
2023
Q4
$579K Buy
19,000
+5,400
+40% +$155K ﹤0.01% 1077
2023
Q3
$430K Hold
13,600
﹤0.01% 1117
2023
Q2
$555K Buy
13,600
+2,800
+26% +$114K ﹤0.01% 1011
2023
Q1
$403K Hold
10,800
﹤0.01% 1112
2022
Q4
$377K Buy
10,800
+1,300
+14% +$61.8K ﹤0.01% 1119
2022
Q3
$532K Hold
9,500
﹤0.01% 927
2022
Q2
$492K Hold
9,500
﹤0.01% 1028
2022
Q1
$690K Sell
9,500
-1,900
-17% -$161K ﹤0.01% 982
2021
Q4
$1.35M Sell
11,400
-2,600
-19% -$326K 0.01% 757
2021
Q3
$1.88M Buy
+14,000
New +$2.12M 0.01% 636
2021
Q2
Sell
-10,300
Closed -$827K 1722
2021
Q1
$827K Buy
10,300
+500
+5% +$33.6K ﹤0.01% 930
2020
Q4
$533K Buy
+9,800
New +$356K ﹤0.01% 1126

Other funds holding NTLA